Published on GHDx (https://ghdx.healthdata.org)

Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint

General Info

Geography 
Switzerland (CHE)
Time period covered 
January, 2021 - December, 2021
Data type
Scientific literature
Keywords 
COVID-19

Citation

Authors 
Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau A, Lamour J, Pennacchio F, Wisniak A, Dumont R, Baysson H, Richard V, Lorthe E, Semaani C, Balavoine JF, Pittet D, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe K, Kaiser L, Guessous I, Specchio-COVID19 study group
Journal 
medRxiv
Publication year 
2021
Suggested citation 
Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau A, Lamour J, Pennacchio F, Wisniak A, Dumont R, Baysson H, Richard V, Lorthe E, Semaani C, Balavoine JF, Pittet D, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe K, Kaiser L, Guessous I, Specchio-COVID19 study group. Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint. medRxiv. 2021.
Source URL:https://ghdx.healthdata.org/record/seroprevalence-anti-sars-cov-2-antibodies-six-months-vaccination-campaign-geneva-switzerland#comment-0